Camber Pharmaceuticals Inc. has launched entecavir tablets, an antiviral medication. Camber said Friday that its entecavir product is available in 30- and 90-count bottle for the 0.5-mg strength and in 30-count bottles for the 1-mg dosage.
PISCATAWAY, N.J. — Camber Pharmaceuticals Inc. has launched entecavir tablets, an antiviral medication.
Camber said Friday that its entecavir product is available in 30- and 90-count bottle for the 0.5-mg strength and in 30-count bottles for the 1-mg dosage.
The drug is a generic version of Baraclude tablets (entecavir) from Bristol-Myers Squibb Co. The product has annual sales exceeding $300 million.
Entecavir is indicated for the treatment of chronic hepatitis B.
NCPA is urging the Trump administration to establish certain exclusions from any tariffs, incentivize U.S. manufacturing through supportive domestic and trade policies, and reform the PBM payment model to strengthen domestic supply chains and reimburse pharmacies fairly.
“Our members serve as healthcare lifelines in communities nationwide — we cannot afford disruptions that leave pharmacy shelves empty,” says NACDS president and CEO.
Persistent U.S. shortages make up most of the total, despite a decline in new shortages.
Analysis charts the emergence and future of advanced therapies.
NPI equips brands with access to over 27,000 structured product attributes, ranging from dietary and sustainability indicators to clean-label claims.
NCPA is urging the Trump administration to establish certain exclusions from any tariffs, incentivize U.S. manufacturing through supportive domestic and trade policies, and reform the PBM payment model to strengthen domestic supply chains and reimburse pharmacies fairly.
“Our members serve as healthcare lifelines in communities nationwide — we cannot afford disruptions that leave pharmacy shelves empty,” says NACDS president and CEO.
“Spending rose again in April, driven largely by consumers continuing to pull purchases forward to stay ahead of tariffs that will inevitably lead to higher prices,” NRF President and CEO Matthew Shay said.
